The Taiwanese vaccine maker, Medigen Vaccine Biologics Corp., said Tuesday that a World Health Organization-led (WHO) clinical trial of its COVID-19 vaccine could be unblinded in March at the earliest.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Culture
Taiwanese calligrapher's works grace The Met in New York
11/22/2024 09:24 PM - Politics
MOFA censured over mishandling of Taiwanese diplomat's death in Brazil
11/22/2024 08:39 PM - Business
Taiwan's October jobless rate falls to 24-year low
11/22/2024 08:16 PM - Business
Taiwan shares soar led by TSMC, after U.S. tech rally
11/22/2024 05:38 PM - Sports
Rare win over Team U.S.A. at Premier12 boosts Taiwan final hopes
11/22/2024 05:11 PM